
Seftza TZ 250mg/31.25mg Injection
Marketer
Swastik Life Sciences
Salt Composition
Ceftazidime (250mg) + Tazobactum (31.25mg)
Overview Seftza TZ 250mg/31.25mg Injection
Tazicef 250mg/31.25mg injection, a dual-action antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation. Administer this medication strictly as directed by a physician. Complete the prescribed treatment regimen, regardless of symptom improvement; premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Report any worsening symptoms immediately. Seek urgent medical attention for allergic reactions (e.g., rash, itching, swelling, dyspnea). Inform your doctor of all current medications, including those for pre-existing conditions, before commencing treatment. Pregnant or lactating individuals require prior medical consultation. Alcohol consumption is discouraged due to potential additive drowsiness. While generally non-impairing to driving, refrain from driving if drowsiness or dizziness occurs. Adequate rest, nutritious food, and hydration support recovery. Your doctor may order laboratory tests to monitor therapeutic response.
Primary Ingredients of Seftza TZ 250mg/31.25mg Injection
There is no text provided to rephrase. Please provide the text you wish me to rewrite.
Uses of Seftza TZ 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Seftza TZ 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Seftza TZ 250mg/31.25mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Stomach pain
- Increased liver enzymes
- Allergic reaction
How to use Seftza TZ 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Seftza TZ 250mg/31.25mg Injection works:
Seftza TZ Injection, containing 250mg Ceftazidime and 31.25mg Tazobactam, utilizes a dual-action approach to combat bacterial infections. Ceftazidime, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to reproduce. Tazobactam, a beta-lactamase inhibitor, counteracts bacterial enzymes that would otherwise inactivate Ceftazidime, thus augmenting its antibacterial effect.
SAFETY ADVICE
AlcoholSAFE
Seftza TZ 250mg/31.25mg Injection does not interact negatively with alcohol consumption.
PregnancySAFE IF PRESCRIBED
The injectable medication Seftza TZ 250mg/31.25mg is usually deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, clinical data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Seftza TZ 250mg/31.25mg is considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer into breast milk, posing no apparent risk to the infant.
DrivingUNSAFE
The injectable medication Seftza TZ 250mg/31.25mg can cause drowsiness, visual disturbances, and dizziness. Refrain from operating a vehicle should these effects manifest.
KidneyCAUTION
Individuals with impaired kidney function should exercise caution when using Seftza TZ 250mg/31.25mg Injection. Dosage modification may be necessary; physician consultation is advised.
LiverCAUTION
Individuals with severe hepatic impairment should use Seftza TZ 250mg/31.25mg Injection cautiously. Dosage modification of Seftza TZ 250mg/31.25mg Injection may be necessary. Medical advice is recommended.
What if you forget to take Seftza TZ 250mg/31.25mg Injection :
Should you forget a scheduled dose of Seftza TZ 250mg/31.25mg Injection, seek medical advice.
Facts to Know About Seftza TZ 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |
